Calypte Biomedical logo

CBMC - Calypte Biomedical Share Price

$0.001 0.0  0.0%

Last Trade - 02/04/15

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £184k
Position in Universe th / 6344
Bullish
Bearish
Unlock CBMC Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
0.59 0.73 0.73 0.44 0.58 0.23 -17.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2012, Calypte Biomedical Corporation revenues decreased 60% to $230K. Net loss increased 55% to $1.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CBMC Revenue Unlock CBMC Revenue

Net Income

CBMC Net Income Unlock CBMC Revenue

Normalised EPS

CBMC Normalised EPS Unlock CBMC Revenue

PE Ratio Range

CBMC PE Ratio Range Unlock CBMC Revenue

Dividend Yield Range

CBMC Dividend Yield Range Unlock CBMC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CBMC EPS Forecasts Unlock CBMC Revenue
Profile Summary

Calypte Biomedical Corporation develops, manufactures and distributes in-vitro diagnostic tests for the diagnosis of Human Immunodeficiency Virus (HIV) infection. The Company focuses on the development and commercialization of its Aware HIV-1/2 rapid tests. It has completed field trials and product evaluations of Aware HIV-1/2 OMT (oral fluid) rapid test. The Company has regulatory approvals in Russia, India, China, Africa, Southeast Asia and the Middle East. The Company markets its products through distributors in South Africa and the United Arab Emirates (U.A.E.). The Company also manufactures and sells HIV-1 BED Incidence EIA test, an Aware BED Incidence Test, through an arrangement with the United States Centers for Disease Control and Prevention (the CDC). The Company’s product line includes its Aware line of tests, its Aware HIV-1 BED Incidence test and its Aware Messenger specimen collection device

Directors
Last Annual December 31st, 2012
Last Interim December 31st, 2012
Incorporated June 11, 1996
Public Since July 26, 1996
No. of Shareholders: n/a
No. of Employees: 4
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 700,168,157
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CBMC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CBMC
Upcoming Events for CBMC
Frequently Asked Questions for Calypte Biomedical
What is the Calypte Biomedical share price?

As of 02/04/15, shares in Calypte Biomedical are trading at $0.001, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Calypte Biomedical share price performed this year?

Shares in Calypte Biomedical are currently trading at $0.001 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Calypte Biomedical price has moved by % over the past year.

What are the analyst and broker recommendations for Calypte Biomedical?

There are no analysts currently covering Calypte Biomedical.

When will Calypte Biomedical next release its financial results?

Calypte Biomedical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2013-12-31
What is the Calypte Biomedical dividend yield?

Calypte Biomedical does not currently pay a dividend.

Does Calypte Biomedical pay a dividend?

Calypte Biomedical does not currently pay a dividend.

When does Calypte Biomedical next pay dividends?

Calypte Biomedical does not currently pay a dividend.

How do I buy Calypte Biomedical shares?

To buy shares in Calypte Biomedical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Calypte Biomedical?

Shares in Calypte Biomedical are currently trading at $0.001, giving the company a market capitalisation of £n/a.

Where are Calypte Biomedical shares listed? Where are Calypte Biomedical shares listed?

Here are the trading details for Calypte Biomedical:

Country of listing: United States
Exchange: PNK
Ticker Symbol: CBMC
What kind of share is Calypte Biomedical?

We were not able to load our ranking data for Calypte Biomedical

Is there a Calypte Biomedical share price forecast 2020?

We were not able to load any forecast data for Calypte Biomedical.

How can I tell whether the Calypte Biomedical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Calypte Biomedical. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $0.001, shares in Calypte Biomedical are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Calypte Biomedical PE Ratio?

We were not able to find PE ratio data for Calypte Biomedical.

Who are the key directors of Calypte Biomedical?

We were unable to find the directors for Calypte Biomedical.

Who are the major shareholders of Calypte Biomedical?

Here are the top five shareholders of Calypte Biomedical based on the size of their shareholding:

Similar to CBMC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.